Hormones and Genes of Importance in Bone Physiology and Their Influence on Bone Mineralization and Growth in Turner Syndrome

被引：10

作者：

Andrade, Anenisia C. ^{[1
]}

Baron, Jeffrey ^{[2
]}

Manolagas, Stavros C. ^{[3
,4
]}

Shaw, Nick J. ^{[5
]}

Rappold, Gudrun A. ^{[7
]}

Donaldson, Malcolm D. C. ^{[6
]}

Gault, Emma Jane ^{[6
]}

Saevendahl, Lars

机构：

[1] Karolinska Inst, Pediat Endocrinol Unit, Dept Woman & Child Hlth, SE-17176 Stockholm, Sweden

[2] NICHD, Sect Growth & Dev, NIH, Bethesda, MD USA

[3] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA

[4] Univ Arkansas Med Sci, Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA

[5] Birmingham Childrens Hosp, Dept Endocrinol, Birmingham, W Midlands, England

[6] Royal Hosp Sick Children, Dept Child Hlth, Glasgow G3 8SJ, Strathclyde, Scotland

[7] Univ Heidelberg, Dept Human Mol Genet, Heidelberg, Germany

来源：

HORMONE RESEARCH IN PAEDIATRICS | 2010年 / 73卷 / 03期

关键词：

Bone; Growth; Turner syndrome; SHOX; Wnt; Oxandrolone; Estrogen; FORKHEAD-BOX-O; T-CELL-FACTOR; SHORT-STATURE; FINAL HEIGHT; SHOX HAPLOINSUFFICIENCY; OXIDATIVE STRESS; BETA-CATENIN; DENSITY; PLATE; FRACTURE;

D O I：

10.1159/000284356

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This mini review summarizes papers presented in a Joint Symposium between the Bone, Growth Plate and Turner Syndrome Working Groups of the European Society for Paediatric Endocrinology (ESPE) that was held on September 9, 2009, in New York. The program had been composed to give an update on hormones and genes of importance in bone physiology and their influence on bone mineralization and growth in Turner syndrome. This paper summarizes the data and highlights the main topics and discussions related to each presentation. Copyright (C) 2010 S. Karger AG, Basel

引用

页码：161 / 165

页数：5

共 31 条

[1] The role of the resting zone in growth plate chondrogenesis [J].

Abad, V ;

Meyers, JL ;

Weise, M ;

Gafni, RI ;

Barnes, KM ;

Nilsson, O ;

Bacher, JD ;

Baron, J .

ENDOCRINOLOGY, 2002, 143 (05) :1851-1857

[2] Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting β-catenin from T cell factor- to Forkhead box O-mediated transcription [J].

Almeida, Maria ;

Han, Li ;

Martin-Millan, Marta ;

O'Brien, Charles A. ;

Manolagas, Stavros C. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (37) :27298-27305

[3] Selective reduction in cortical bone mineral density in Turner syndrome independent of ovarian hormone deficiency [J].

Bakalov, VK ;

Axelrod, L ;

Baron, J ;

Hanton, L ;

Nelson, LM ;

Reynolds, JC ;

Hill, S ;

Troendle, J ;

Bondy, CA .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12) :5717-5722

[4] Fracture risk and bone mineral density in Turner syndrome [J].

Bakalov, Vladimir K. ;

Bondy, Carolyn A. .

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2008, 9 (02) :145-151

[5] Expression of cyclin-dependent kinase inhibitors in epiphyseal chondrocytes induced to terminally differentiate with thyroid hormone [J].

Ballock, RT ;

Zhou, XL ;

Mink, LM ;

Chen, DHC ;

Mita, BC ;

Stewart, MC .

ENDOCRINOLOGY, 2000, 141 (12) :4552-4557

[6] Musculoskeletal analyses of the forearm in young women with Turner syndrome: A study using peripheral quantitative computed tomography [J].

Bechtold, S ;

Rauch, F ;

Noelle, V ;

Donhauser, S ;

Neu, CM ;

Schoenau, E ;

Schwarz, HP .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (12) :5819-5823

[7] The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice [J].

Bodine, PVN ;

Zhao, WG ;

Kharode, YP ;

Bex, FJ ;

Lambert, AJ ;

Goad, MB ;

Gaur, T ;

Stein, GS ;

Lian, JB ;

Komm, BS .

MOLECULAR ENDOCRINOLOGY, 2004, 18 (05) :1222-1237

[8] Clinical practice guideline - Care of girls and women with Turner syndrome: A guideline of the Turner Syndrome Study Group [J].

Bondy, Carolyn A. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (01) :10-25

[9] Final height of patients with Turner's syndrome treated with growth hormone (GH): Indications for GH therapy alone at high doses and late estrogen therapy [J].

Cacciari, E ;

Mazzanti, L .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (12) :4510-4515

[10]

CHEN J, 2009, J MED GENET

← 1 2 3 4 →